Written by GaryDOW ends down 1.4% in worst day since February; Nasdaq claws back to flat line (SPY -0.9%). Big-tech bloodbath continues after biggest sell-program in history.
I think the great success of the mRNA vaccines in addressing Covid-19 has clearly opened up a large number of possibilities, Jansen said in comments that aired Tuesday during CNBC s Healthy Returns Summit. We want to have better vaccines for older individuals who are at risk for severe disease, she said in the interview with CNBC s Meg Tirrell. This is in my mind a very powerful approach to get us to ultimately more potent seasonal influenza vaccines.
Jansen s comments come after Pfizer had huge success with its mRNA-based Covid-19 vaccine.
Messenger RNA, or mRNA, technology has been under development for years, but Pfizer s and Moderna s Covid-19 vaccines are the first time mRNA has been cleared for use in humans. The mRNA-based Covid vaccine works by tricking the body to produce a harmless piece of the virus, triggering an immune response. It s said to be easier to produce over traditional vaccines, which generally use a dead or weakened virus to produce an immune respons
I think the great success of the mRNA vaccines in addressing Covid-19 has clearly opened up a large number of possibilities, Jansen said in comments that aired Tuesday during CNBC s Healthy Returns Summit. We want to have better vaccines for older individuals who are at risk for severe disease, she said in the interview with CNBC s Meg Tirrell. This is in my mind a very powerful approach to get us to ultimately more potent seasonal influenza vaccines.
Jansen s comments come after Pfizer had huge success with its mRNA-based Covid-19 vaccine.
Messenger RNA, or mRNA, technology has been under development for years, but Pfizer s and Moderna s Covid-19 vaccines are the first time mRNA has been cleared for use in humans. The mRNA-based Covid vaccine works by tricking the body to produce a harmless piece of the virus, triggering an immune response. It s said to be easier to produce over traditional vaccines, which generally use a dead or weakened virus to produce an immune respons
By James Rosen
LIKE SO MANY other Americans, I cheered in awe and happy disbelief last year as a band of driven, brainy scientists worked at breakneck speed to develop a vaccine to stop a pandemicâs deadly rampage across the globe.
Sacrificing sleep, foregoing family time, fueled by adrenaline and hope, a small group of immunologists and virologists collaborated across borders to achieve the impossible: create a new type of vaccine from scratch in a fraction of the time previously required to create the inoculations that had conquered past pandemics.
They didnât have the four decades it took before British physician Edward Jenner unveiled the smallpox vaccine in 1796, the first in world history. They didnât have the 12 years needed to unveil the flu vaccine in 1945, which to this day is only about 50 percent effective. They didnât even have the five years it took Dr. Jonas Salk to develop the polio vaccine, considered a medical miracle when he annou
CBS News
Full transcript of Face the Nation on May 2, 2021
Ronald Klain, White House Chief of Staff
Sen. Tim Scott, R- South Carolina
Dr. Scott Gottlieb, Former FDA Commissioner
Click here to browse full transcripts of Face the Nation.
JOHN DICKERSON: I m John Dickerson in Washington. And this week on FACE THE NATION, we ll talk exclusively with two key players in the drama that s likely to impact every American. President Biden is pitching the most ambitious and most expensive set of domestic reforms in decades. Together his proposals total more than six trillion dollars in new spending. Do we need it all, and how are we going to pay for it?